Spandidos出版社期刊
期刊
会议
图书
作者:Tamaki Tamanuki , Tomoyoshi Aoyagi , Akiyuki Murano ...
来源:[J].Molecular and Clinical Oncology, 2018, Vol.9 (2), pp.215-218Spandidos
摘要:An 83‑year‑old woman underwent mastectomy for breast cancer of the rightbreast in 2008. In addition to hormone therapy and irradiation, zoledronate wasstarted for bone metastasis 6 months postoperatively. Five years after the operation,the patient developed osteonecrosis of ...
作者:Ziling Zhao , Shuna Yang , Yan Cheng ...
来源:[J].Molecular Medicine Reports(IF 1.17), 2018, Vol.18 (2), pp.1878-1884Spandidos
摘要:In recent years, microRNAs (miRNAs/miRs) have been shown to be deregulatedin epithelial ovarian cancer (EOC). Their deregulation has been suggested to beinvolved in EOC formation and progression through the regulation of the expressionof numerous cancer‑related genes. Hence,...
作者:Fangmiao Yu , Yaru Zhang , Lei Ye ...
来源:[J].Molecular Medicine Reports(IF 1.17), 2018, Vol.18 (1), pp.771-778Spandidos
摘要:Prostate cancer is the main causes of cancer associated mortality in menworldwide, cancer patients often suffer serious side effects when treated withchemotherapy or radiotherapy, therefore novel drugs are in high demand to treatprostate cancer. In the present study, a penta...
作者:Shibo Zhu , Liyu Zhang , Zhang Zhao ...
来源:[J].Oncology Reports(IF 2.297), 2018, Vol.40 (2), pp.571-578Spandidos
摘要:Dysregulation of miR‑92a‑3p has been shown to contribute to many tumorigenicprocesses, and is correlated with tumor progression and prognosis. However, theassociation between miR‑92a‑3p and the clinicopathological features of Wilms tumorandits regulatory mechanism remai...
作者:Yaling Qi , Wenjie Zhao , Mengsen Li ...
来源:[J].International Journal of Oncology(IF 2.657), 2018, Vol.53 (1), pp.358-370Spandidos
摘要:The present study aimed to examine the effects and mechanisms of exogenousC-X-C motif chemokine 5 (CXCL5) and lentiviral CXCL5 overexpression on the regulationof malignant behaviors of prostate cancer cells in vitro and in a nude mouse xenograftmodel. The expression levels o...
作者:Diana Fisler , Dhiraj Sikaria , John Yavorski ...
来源:[J].Oncology Letters(IF 0.237), 2018, Vol.16 (2), pp.2757-2763Spandidos
摘要:Overstimulation of pro‑proliferative pathways and high level expressionof pro‑proliferative transcription factors (TFs) can lead to apoptosis. This islikely due to TF binding sites for pro‑proliferative TFs common to pro‑proliferativeand pro‑apoptosis‑effector gene...
作者:Zhichun Liu , Jingwu Sun , Bin Liu ...
来源:[J].International Journal of Molecular Medicine(IF 1.957), 2018, Vol.42 (1), pp.141-148Spandidos
摘要:The present study aimed to investigate molecular mechanisms associated withliver cancer and provide a possible therapeutic target for the treatment of livercancer. Liver cancer patients that were diagnosed and treated at the Central Hospitalof China National Petroleum Corp. ...
作者:Xinrong Wang , Hongchu Bao , Xuemei Liu ...
来源:[J].Oncology Letters(IF 0.237), 2018, Vol.16 (1), pp.1115-1122Spandidos
摘要:The present study investigated the effects of endometrial stem cell (EnSCs)transplantation combined with estrogen in the repair of endometrial injury. Atotal of 30 patients with intrauterine adhesions (IUA) and 30 healthy individualswere selected. Expression of epidermal gro...
作者:Bi‑Dan Hu , Jia Guo , Yuan‑Zi Ye ...
来源:[J].Oncology Reports(IF 2.297), 2018, Vol.40 (1), pp.155-164Spandidos
摘要:Notch‑3 is a receptor of the Notch signaling pathway and plays an importantrole in regulating self‑renewal, differentiation and apoptosis in cancer cells.Overexpression of Notch‑3 has been proved to be associated with resistance togemcitabine (GEM) and poor patient prog...
作者:Baoshan Li , Shouke Geng , Yuanli Dai
来源:[J].Experimental and Therapeutic Medicine(IF 0.344), 2018, Vol.16 (2), pp.891-895Spandidos
摘要:Therapeutic effect of vascular interventional therapy and aspirin combinedwith defibrase in the treatment of cerebral ischemia in rat model were investigated.Ninety rats were selected to establish cerebral ischemia model. Animal modelswere randomly divided into observation group ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×